These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 24112036

  • 1. Neuroprotective and anti-apoptotic effects of liraglutide on SH-SY5Y cells exposed to methylglyoxal stress.
    Sharma MK, Jalewa J, Hölscher C.
    J Neurochem; 2014 Feb; 128(3):459-71. PubMed ID: 24112036
    [Abstract] [Full Text] [Related]

  • 2. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
    McClean PL, Hölscher C.
    Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
    [Abstract] [Full Text] [Related]

  • 3. The protective effects of liraglutide on AD-like neurodegeneration induced by oxidative stress in human neuroblastoma SH-SY5Y cells.
    Zheng C, Zhou M, Sun J, Xiong H, Peng P, Gu Z, Deng Y.
    Chem Biol Interact; 2019 Sep 01; 310():108688. PubMed ID: 31173752
    [Abstract] [Full Text] [Related]

  • 4. Liraglutide prevents beta-amyloid-induced neurotoxicity in SH-SY5Y cells via a PI3K-dependent signaling pathway.
    Liu XY, Wang LX, Chen Z, Liu LB.
    Neurol Res; 2016 Apr 01; 38(4):313-9. PubMed ID: 27108910
    [Abstract] [Full Text] [Related]

  • 5. Novel incretin analogues improve autophagy and protect from mitochondrial stress induced by rotenone in SH-SY5Y cells.
    Jalewa J, Sharma MK, Hölscher C.
    J Neurochem; 2016 Oct 01; 139(1):55-67. PubMed ID: 27412483
    [Abstract] [Full Text] [Related]

  • 6. The human glucagon-like peptide-1 analogue liraglutide regulates pancreatic beta-cell proliferation and apoptosis via an AMPK/mTOR/P70S6K signaling pathway.
    Miao XY, Gu ZY, Liu P, Hu Y, Li L, Gong YP, Shu H, Liu Y, Li CL.
    Peptides; 2013 Jan 01; 39():71-9. PubMed ID: 23116613
    [Abstract] [Full Text] [Related]

  • 7. Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells.
    Li Y, Tweedie D, Mattson MP, Holloway HW, Greig NH.
    J Neurochem; 2010 Jun 01; 113(6):1621-31. PubMed ID: 20374430
    [Abstract] [Full Text] [Related]

  • 8. Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease.
    McClean PL, Hölscher C.
    Neuropharmacology; 2014 Nov 01; 86():241-58. PubMed ID: 25107586
    [Abstract] [Full Text] [Related]

  • 9. Mutated recombinant human glucagon-like peptide-1 protects SH-SY5Y cells from apoptosis induced by amyloid-beta peptide (1-42).
    Qin Z, Sun Z, Huang J, Hu Y, Wu Z, Mei B.
    Neurosci Lett; 2008 Oct 31; 444(3):217-21. PubMed ID: 18760331
    [Abstract] [Full Text] [Related]

  • 10. Liraglutide, a human glucagon-like peptide-1 analogue, stimulates AKT-dependent survival signalling and inhibits pancreatic β-cell apoptosis.
    Kapodistria K, Tsilibary EP, Kotsopoulou E, Moustardas P, Kitsiou P.
    J Cell Mol Med; 2018 Jun 31; 22(6):2970-2980. PubMed ID: 29524296
    [Abstract] [Full Text] [Related]

  • 11. Liraglutide is neurotrophic and neuroprotective in neuronal cultures and mitigates mild traumatic brain injury in mice.
    Li Y, Bader M, Tamargo I, Rubovitch V, Tweedie D, Pick CG, Greig NH.
    J Neurochem; 2015 Dec 31; 135(6):1203-1217. PubMed ID: 25982185
    [Abstract] [Full Text] [Related]

  • 12. ERK- and Akt-dependent neuroprotection by erythropoietin (EPO) against glyoxal-AGEs via modulation of Bcl-xL, Bax, and BAD.
    Shen J, Wu Y, Xu JY, Zhang J, Sinclair SH, Yanoff M, Xu G, Li W, Xu GT.
    Invest Ophthalmol Vis Sci; 2010 Jan 31; 51(1):35-46. PubMed ID: 19628748
    [Abstract] [Full Text] [Related]

  • 13. Glucagon-like Peptide-1 Analogues Inhibit Proliferation and Increase Apoptosis of Human Prostate Cancer Cells in vitro.
    Li XN, Bu HM, Ma XH, Lu S, Zhao S, Cui YL, Sun J.
    Exp Clin Endocrinol Diabetes; 2017 Feb 31; 125(2):91-97. PubMed ID: 28008585
    [Abstract] [Full Text] [Related]

  • 14. Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease.
    Hölscher C.
    Biochem Soc Trans; 2011 Aug 31; 39(4):891-7. PubMed ID: 21787319
    [Abstract] [Full Text] [Related]

  • 15. Liraglutide improves hippocampal synaptic plasticity associated with increased expression of Mash1 in ob/ob mice.
    Porter WD, Flatt PR, Hölscher C, Gault VA.
    Int J Obes (Lond); 2013 May 31; 37(5):678-84. PubMed ID: 22665137
    [Abstract] [Full Text] [Related]

  • 16. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
    Ligumsky H, Wolf I, Israeli S, Haimsohn M, Ferber S, Karasik A, Kaufman B, Rubinek T.
    Breast Cancer Res Treat; 2012 Apr 31; 132(2):449-61. PubMed ID: 21638053
    [Abstract] [Full Text] [Related]

  • 17. Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: a link between diabetes and Alzheimer's disease.
    McClean PL, Gault VA, Harriott P, Hölscher C.
    Eur J Pharmacol; 2010 Mar 25; 630(1-3):158-62. PubMed ID: 20035739
    [Abstract] [Full Text] [Related]

  • 18. The role of GLP-1/GIP receptor agonists in Alzheimer's disease.
    Yu CJ, Ma D, Song LL, Zhai ZN, Tao Y, Zhang Y, Cai LY, Hou YH, Chen HY, Wang L.
    Adv Clin Exp Med; 2020 Jun 25; 29(6):661-668. PubMed ID: 32614526
    [Abstract] [Full Text] [Related]

  • 19. Gamma-hydroxybutyrate, acting through an anti-apoptotic mechanism, protects native and amyloid-precursor-protein-transfected neuroblastoma cells against oxidative stress-induced death.
    Wendt G, Kemmel V, Patte-Mensah C, Uring-Lambert B, Eckert A, Schmitt MJ, Mensah-Nyagan AG.
    Neuroscience; 2014 Mar 28; 263():203-15. PubMed ID: 24456637
    [Abstract] [Full Text] [Related]

  • 20. Epidermal growth factor receptor transactivation is necessary for glucagon-like peptide-1 to protect PC12 cells from apoptosis.
    Kimura R, Okouchi M, Kato T, Imaeda K, Okayama N, Asai K, Joh T.
    Neuroendocrinology; 2013 Mar 28; 97(4):300-8. PubMed ID: 23147408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.